Our Team
Vancouver Ketamine Infusions was developed to help people suffering from severe mood disorders, neuropathic pain, and migraines. The practice is extremely proud of its work, allowing patients to recover from their illnesses and get back to being the best version of themselves. Our team incorporates the latest research into their practice and gives their patients the safest and highest level of care.
Karl Hare MSA, CRNA, ARNP
Karl is a National Board-Certified Registered Nurse Anesthesiologist with 29 years of healthcare experience. He received his Associate Degree of Nursing from Walla Walla Community College in 1993. Bachelor of Science from Portland State University in 1997. He then pursued a degree in Anesthesia, becoming a CRNA, and graduating with a Master of Science in Anesthesia from Middle Tennessee School of Anesthesia in 2001.
Karl has served on medical mission trips from Africa to Brazil. In addition, Karl has spent 21 years giving anesthesia in hospitals, surgery centers and medical office settings, such as neurosurgery, cardiothoracic & vascular surgery, trauma surgery, orthopedics, pediatric surgery, obstetrics, general surgery, plastic & reconstructive surgery, chronic pain management, and more. Karl desires to help those suffering from psychological and physical pains.
“My mission is to educate and raise awareness that there is hope for a better quality of life, with safe, effective treatments available right now for severe depression, anxiety, suicidal ideation, PTSD, neuropathic pain, and many other physical and emotional conditions that cause deep suffering.”
Our Mission
Our mission is to bring hope and improve the lives of those who put their trust in us. We take this responsibility seriously and commit significant resources to keep our facility safe and staffed with experienced and talented National Board-Certified Registered Nurse Anesthesiologists (CRNAs’). In addition, we vow to keep up with the latest research and treatments, ensuring you the best treatment possible and the highest likelihood of success. Our secondary mission is to make ketamine treatments and sphenopalatine ganglion blocks more recognized and available to those suffering and who may benefit from treatment.
Marci Hare MSA, CRNA, ARNP